Reactive oxygen species (ROS) play a dual role in apoptosis induction, acting both as pro-apoptotic agents and as anti-apoptotic factors. ROS are generated by inflammatory cells, particularly in phagocytes, through the NADPH oxidase, leading to the respiratory burst. ROS can induce apoptosis by triggering the release of cytochrome c from mitochondria, which activates caspases. This process is mediated by ROS, which can also activate sphingomyelinase, generating ceramide, an intracellular mediator of apoptosis. ROS can also activate anti-apoptotic pathways, such as those involving NF-κB, leading to the expression of anti-apoptotic genes like superoxide dismutase and catalase. Death receptors, such as the Fas receptor and TNF receptors, are involved in apoptosis and can be activated by ROS. ROS can induce apoptosis by causing tyrosine phosphorylation, which affects apoptosis-regulating proteins. ROS can also induce the expression of Fas and Fas ligand genes. Mitochondria are both sources and targets of ROS. The release of cytochrome c from mitochondria is a critical step in apoptosis, and ROS can contribute to this release by disrupting the mitochondrial membrane potential. ROS can also activate the mitochondrial permeability transition, leading to increased ROS release. NO, a radical species, can induce apoptosis in various cell systems and is involved in anti-cancer mechanisms. NO can block apoptosis by inducing heatshock proteins, which increase intracellular glutathione levels, opposing ROS-induced apoptosis. NO also has anti-apoptotic effects, depending on its concentration. Increased NO levels in allergic tissues may contribute to Fas receptor resistance in eosinophils, contributing to tissue eosinophilia. Overall, ROS and NO play complex roles in apoptosis regulation, particularly in inflammatory cells.Reactive oxygen species (ROS) play a dual role in apoptosis induction, acting both as pro-apoptotic agents and as anti-apoptotic factors. ROS are generated by inflammatory cells, particularly in phagocytes, through the NADPH oxidase, leading to the respiratory burst. ROS can induce apoptosis by triggering the release of cytochrome c from mitochondria, which activates caspases. This process is mediated by ROS, which can also activate sphingomyelinase, generating ceramide, an intracellular mediator of apoptosis. ROS can also activate anti-apoptotic pathways, such as those involving NF-κB, leading to the expression of anti-apoptotic genes like superoxide dismutase and catalase. Death receptors, such as the Fas receptor and TNF receptors, are involved in apoptosis and can be activated by ROS. ROS can induce apoptosis by causing tyrosine phosphorylation, which affects apoptosis-regulating proteins. ROS can also induce the expression of Fas and Fas ligand genes. Mitochondria are both sources and targets of ROS. The release of cytochrome c from mitochondria is a critical step in apoptosis, and ROS can contribute to this release by disrupting the mitochondrial membrane potential. ROS can also activate the mitochondrial permeability transition, leading to increased ROS release. NO, a radical species, can induce apoptosis in various cell systems and is involved in anti-cancer mechanisms. NO can block apoptosis by inducing heatshock proteins, which increase intracellular glutathione levels, opposing ROS-induced apoptosis. NO also has anti-apoptotic effects, depending on its concentration. Increased NO levels in allergic tissues may contribute to Fas receptor resistance in eosinophils, contributing to tissue eosinophilia. Overall, ROS and NO play complex roles in apoptosis regulation, particularly in inflammatory cells.